Pesquisar um projeto de investigação
Outras opções de pesquisa
182 Resultado(s)
Financiado por um membro do IRDiRC = Membro de uma ERN =
Projetos de investigação

Baden-Württemberg
HEIDELBERG
ERA-NET TRANSCAN: BRCAddict - BRCAness as a therapeutic target for solid high-risk childhood tumors
Deutsches Krebsforschungszentrum
KITZ - Hopp-Kindertumorzentrum Heidelberg

WIEN
ADDRESS: NOT PROVIDED - AT
A Quality Improvement Project to Implement Psychosocial Care Standards in Clinical Practice in Pediatric Oncology "My Logbook! - I Know my Way Around!" Development and Evaluation of a Consensus and Evidence Based Psychosocial Therapy Tool in a Preliminary Psychosocial Study on Therapy Optimization - AT
Institution: Information not provided - AT

WIEN
WIEN
PanCareSurPass: PanCare studies of the scale-up and implementation of the digital Survivorship Passport to improve people-centred care for childhood cancer survivors - AT
Gesundheit Österreich GmbH

WIEN
WIEN
Christian Doppler Laboratory for Next Generation CAR-T Cells
St. Anna Kinderkrebsforschung
Children's Cancer Research Institute

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
Follow-up of Fertility in Young Adults Who Did or Did Not Store Testicular Tissue Before Gonadotoxic Treatment for Fertility Preservation
Universitair Ziekenhuis Brussel
Universitair Ziekenhuis Brussel (UZ Brussel)

Ontario
TORONTO
Beyond the Genome: Transcriptome Based Diagnostics for Rare Diseases and Cancer
Hospital for Sick Children, Research Institute

Washington
ADDRESS: NOT PROVIDED - US
Evaluating utility and improving implementation of genomic sequencing for pediatric cancer patients in the diverse population and healthcare settings of Texas: the kidscanseq study
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Personalized whole body staging for children with cancer: a solution to the conundrum of long-term side effects from ct and pet/ct scans
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Project 1: optimization of therapeutic approaches for children with relapsed sarcomas using precision medicine.
Institution: Information not provided - US

ILE-DE-FRANCE
ORSAY
DCD-CANC-CHILD: design of drug carrier and delivery control for cancer therapy of children
Université Paris-Sud
Institut de Chimie Moléculaire et des Matériaux d'Orsay

VENETO
PADOVA
Modulating BMP axis to prevent muscle loss, dismantling of NMJ and denervation in cancer cachexia
Venetian Institute of Molecular Medicine
Fondazione per la ricerca Biomedica avanzata ONLUS

Suisse Alémanique
WINTERTHUR
Brain Tumor Detection and Classification from a Single MRI Slice Using Convolutional Neural Networks
Kantonsspital Winterthur
Institut für Radio-Onkologie

Nordrhein-Westfalen
BONN
Functional role of genes and pathways in histone H3 mutated gliomas
Deutsche Forschungsgemeinschaft

Nordrhein-Westfalen
MÜNSTER
Functional role of genes and pathways in histone H3 mutated gliomas
Institut für Neuropathologie der Medizinischen Fakultät Münster
Institut für Neuropathologie

Rheinland-Pfalz
MAINZ
BLU-Men: Psychological stress and quality of life in patients with untreated MENingeomas
Universitätsmedizin Mainz
Neurochirurgische Klinik und Poliklinik

Rheinland-Pfalz
MAINZ
GLIOPT -Glioma patients in ambulatory care - Optimization of psychosocial care in neurooncological patients
Universitätsmedizin Mainz
Universitäres Centrum für Tumorerkrankungen (UCT) Mainz

WIEN
ADDRESS: NOT PROVIDED - AT
The ROAM trial: Radiation versus Observation following surgical resection of Atypical Meningioma: a randomised controlled trial - AT
Institution: Information not provided - AT

WIEN
ADDRESS: NOT PROVIDED - AT
GliMR2.0: Glioma MR Imaging 2.0 - AT
Institution: Information not provided - AT

WIEN
WIEN
E-TRAB: Geriatric Assessment of Elderly "Unsuited" Patients Receiving Trabectedin in First Line Treatment For Advanced Soft Tissue Sarcomas - AT
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Onkologie

WIEN
WIEN
Intraoperative visualization of diagnostic tissue with 5-ALA induced PpIXfluorescence measurement in stereotactic biopsies of suspected brain tumors
Allgemeines Krankenhaus der Stadt Wien
Universitätsklinik für Neurochirurgie

WIEN
WIEN
Improved Visualization and Resection of Brain Tumors with Quantitative Fluorescence and Optical Coherence Tomography
Allgemeines Krankenhaus der Stadt Wien
Universitätsklinik für Neurochirurgie

WIEN
WIEN
MEN-301: A Phase 3 Multicenter Study of Gleolan (Aminolevulinic Acid Hydrochloride) to Enhance Visualization of Tumor in Patients With Newly Diagnosed or Recurrent Meningiomas - AT
Allgemeines Krankenhaus der Stadt Wien
Universitätsklinik für Neurochirurgie

WIEN
WIEN
ITCC-P4: Pediatric Preclinical Proof of Concept Platform - AT
Medizinische Universität Wien
Institut für Krebsforschung

WIEN
WIEN
Magnetic Resonance Fingerprinting of Patients with Gliomas
Medizinische Universität Wien
Exzellenzzentrum für Hochfeld-MR

Cataluña
BARCELONA
Study of endoscopic multiportal minimally invasive neurosurgical pathways for complex brain tumors. Design of new anatomical models and clinical translation
Hospital Clínic de Barcelona
Servicio de Neurocirugía

South Dakota
SIOUX FALLS
Molecular and Cellular Mechanisms of Choroid Plexus Tumor
Sanford Research
Zhao Lab

Washington
ADDRESS: NOT PROVIDED - US
Targeting histone demethylase activity for the treatment of pediatric brainstem glioma
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Establishing the genomic landscape of human atypical meningiomas
Institution: Information not provided - US

County Dublin
DUBLIN
Are Gliomas in Adults Associated With a Unique Identifying Blood Biomarker Signature?
Beaumont Hospital
Medical Oncology Service

County Dublin
GLASNEVIN
Are Gliomas in Adults Associated With a Unique Identifying Blood Biomarker Signature?
Cancer Trials Ireland

CENTRO
BRAGA
Potenciais biomarcadores preditivos da resposta a terapias anti-RTKs em gliomas: estudo in vitro e in vivo.
Universidade do Minho
Grupo de Neurociências

SUL
LISBOA
Papel da proteína cinase WNK2 como gene supressor de gliomas malignos
Instituto Nacional de Saúde Dr. Ricardo Jorge - Lisboa
Unidade de Investigação e Desenvolvimento

Region Uppsala
UPPSALA
Molecular mechanisms of the origine of glioma development
Uppsala Universitet
Department of Immunology, Genetics and Pathology

Suisse Alémanique
BERN
Metabolic Characterization of Space Occupying Lesions of the Brain Using in Vivo MR- (Spectroscopic) Imaging at 3 Tesla and 7 Tesla
University Hospital Inselspital
Universitätsinstitut für Diagnostische und Interventionelle Neuroradiologie

Suisse Alémanique
ZÜRICH
To reveal and target molecular interactions causative for pro-invasive signaling in malignant brain tumors
Universitäts-Kinderspital Zürich
Abteilung Onkologie - Experimental Infectious Diseases and Cancer Research

Baden-Württemberg
HEIDELBERG
INFORM-Registry: INdividualized Therapy FOr Relapsed Malignancies in Childhood
Deutsches Krebsforschungszentrum
Klinische Kooperationseinheit Pädiatrische Onkologie

Hamburg
HAMBURG
International HIT-MED Registry (I-HIT-MED) for Children, Adolescents, and Adults With Medulloblastoma, Ependymoma, Pineoblastoma, CNS-primitive Neuroectodermal Tumour
UKE - Universitätsklinikum Hamburg-Eppendorf
Klinik und Poliklinik für Pädiatrische Hämatologie und Onkologie

Nordrhein-Westfalen
BONN
Clinical and molecular features predicting outcome in children with atypical teratoid/rhabdoid tumour (AT/RT)
Deutsche Forschungsgemeinschaft

Nordrhein-Westfalen
ESSEN
HIT-REZ-REGISTRY: Multinational multicenter registry for Children, adolescent and young adult with therapy-refractory, progressive or recurrent medulloblastoma, pineoblastoma, CNS primitive neuroectodermal tumor (CNS PNET) and ependymoma
Universitätsklinikum Essen
Klinik für Kinderheilkunde III - Abteilung für pädiatrische Hämatologie und Onkologie

Nordrhein-Westfalen
MÜNSTER
Clinical and molecular features predicting outcome in children with atypical teratoid/rhabdoid tumour (AT/RT)
Institut für Neuropathologie der Medizinischen Fakultät Münster
Institut für Neuropathologie

WIEN
WIEN
BRCAddict: Harnessing BRCAness as a therapeutic target in high-risk pediatric solid tumors - AT
Allgemeines Krankenhaus der Stadt Wien
Universitätsklinik für Kinder- und Jugendheilkunde

VLAAMS BRABANT
LEUVEN
Longitudinal Analysis of the Health-related Quality of Life in Glioma Patients and Setting up a Large-scale, Prospective Database for Glioma Patients Treated in UZ Leuven - BE
UZ Leuven - Campus Gasthuisberg
Dienst Neurochirurgie

Ontario
TORONTO
Molecular Determinants of Li-Fraumeni Syndrome Associated Cancers
Hospital for Sick Children, Research Institute

Québec
MONTRÉAL
Identification and characterization of genes involved in the genesis and progression of pediatric astrocytomas
Montreal Children's Hospital Research Institute - McGill University
Department of Pediatrics / Département de pédiatrie

Québec
MONTRÉAL
Role of chromatin remodeling in the genesis of pediatric and young adult astrocytomes
Montreal Children's Hospital Research Institute - McGill University
Department of Pediatrics / Département de pédiatrie

Québec
MONTRÉAL
The ICHANGE (International CHildhood Astrocytomas iNtegrated Genomics and Epigenomics) Consortium
Montreal Children's Hospital Research Institute - McGill University
Department of Pediatrics / Département de pédiatrie

Asturias
OVIEDO
Production of an advanced drug therapy for the treatment of rare epithelial diseases at an affordable cost for the National Health System.
Centro Comunitario de Sangre y Tejidos de Asturias

South Dakota
SIOUX FALLS
Study of the molecular mechanisms of medulloblastoma initiation and progression
Sanford Research
Zhao Lab

Washington
ADDRESS: NOT PROVIDED - US
Glycolytic regulation of cerebellar development and medulloblastoma tumorigenesis
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Precision medicine for pediatric low-grade gliomas
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Functional genomic analysis of neural crest development
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Mir-155 and runx function in neurofibroma tumorigenesis and therapy
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Regulation of medulloblastoma metastasis by emp1
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Regulation of shh signaling by cellular energetics
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Targeting mechanisms of medulloblastoma formation
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Targeting wee1 in myc driven medulloblasoma
Institution: Information not provided - US

ILE-DE-FRANCE
VILLEJUIF
BRCAddict: Harnessing BRCAness as a therapeutic target in high-risk pediatric solid tumors - FR (Partener 1)
CLCC Institut Gustave Roussy
Département de Cancérologie de l'enfant et de l'adolescent

MARCHE
ANCONA
Incidence, Clinical Management and Molecular Factors Associated With the Development of Immune-related Adverse Events in Cancer Patients Receiving PD-1 and PD-L1 Inhibitors: a Prospective Observational Study
Università Politecnica delle Marche - Polo Didattico
Istituto di Clinica Medica

Greater London
LONDON
Use of DTT to Define Facial Nerve Position in Vestibular Schwannomas
King's College Hospital
King's College Hospital NHS Foundation Trust HQ

Region Stockholm
STOCKHOLM
Novel targeted therapy for childhood cancer with emphasis on Wip-1 in medulloblastoma and neuroblastoma
Karolinska Institutet - Solna
Department of Women's and Children's Health

Region Stockholm
STOCKHOLM
INTENT: innovative approach for treatment of neuroblastoma and medulloblastoma
Karolinska Institutet - Solna
Department of microbiology, tumor and cell biology

Nordrhein-Westfalen
KÖLN
Molecular basis for tumor suppression and spontanous regression in neuroblastoma
Universitätsklinikum Köln
Pädiatrische Onkologie und Hämatologie

Sachsen
LEIPZIG
NB-MolBiol-2020: Study on the clinical significance of cell biological parameters in diagnostics, prognosis and therapy for neuroblastoma patients
Zentrum für Frauen- und Kindermedizin am Universitätsklinikum Leipzig
Abteilung für Pädiatrische Onkologie, Hämatologie und Hämostaseologie

SALZBURG
SALZBURG
Adjuvant multimodal metabolic therapy of neuroblastoma
Universitätsklinikum der Paracelsus Medizinischen Privatuniversität
Universitätsklinik für Kinder- und Jugendheilkunde

WIEN
ADDRESS: NOT PROVIDED - AT
Cochlear Implantation After Gamma Knife Radiosurgery With Evoked Auditory Brain-Stem Response (eABR) and Correlation to Postoperative Hearing Results - a Pilot Study
Institution: Information not provided - AT

WIEN
WIEN
Simultaneous Translabyrinthine Surgery of Vestibular Schwannoma and Cochlear Implantation With Intraoperative eBERA and Correlation to Hearing Results - a Pilot Study
Allgemeines Krankenhaus der Stadt Wien
Universitätsklinik für Hals-, Nasen- und Ohrenheilkunde

WIEN
WIEN
Identifying immunological characteristics associated with disease progression in low grade glioma
Allgemeines Krankenhaus der Stadt Wien
Universitätsklinik für Neurochirurgie

WIEN
WIEN
Quantitative measurement of 5-ALA fluorescence for improved detection of low-grade gliomas
Allgemeines Krankenhaus der Stadt Wien
Universitätsklinik für Neurochirurgie

WIEN
WIEN
Pharmacokinetics of different antibiotics in cerebrospinal fluid in children with malignant brain tumors - a pilot study
Allgemeines Krankenhaus der Stadt Wien
Universitätsklinik für klinische Pharmakologie

WIEN
WIEN
Bridging cell states and interactions in sympatho-adrenal development for curing neural crest tumors
Medizinische Universität Wien

WIEN
WIEN
LIQUIDHOPE: Advancing Liquid Biopsies for Monitoring and Personalized Treatment of Children with Neuroblastomas - AT
St. Anna Kinderkrebsforschung
Children's Cancer Research Institute

WIEN
WIEN
PRIMAGE: PRedictive In-silico Multiscale Analytics to support cancer personalized diaGnosis and prognosis, Empowered by imaging biomarkers - AT
St. Anna Kinderkrebsforschung
Children's Cancer Research Institute

WIEN
WIEN
A Post-Authorisation Safety Study Patient Registry of Patients With High-risk Neuroblastoma Being Treated With the Monoclonal Antibody Dinutuximab Beta - AT
St. Anna Kinderkrebsforschung
Children's Cancer Research Institute

WIEN
WIEN
Ultra-high-risk pediatric cancer - combinatorial drivers and therapeutic targets for precision medicine
St. Anna Kinderkrebsforschung
Children's Cancer Research Institute

KOREA, REPUBLIC OF
SEOUL
Elimination of Hypoxia Inducible Factor 2 (HIF-2) in neuroblastoma tumor stem cells to stop its metastasis
Seoul National University Hospital
Molecular Diagnostics Laboratory

Cataluña
BARCELONA
Targeting kinesins as new therapeutic approach for high-risk neuroblastoma patients
Vall d'Hebron Institut de Recerca VHIR
Grupo de investigación traslacional en cáncer en la infancia y la adolescencia

Madrid
MADRID
Therapy for treatment of neuroblastoma based on the use of the CRISPR/Cas9 gene editing system
Centro Nacional de Investigaciones Oncológicas (CNIO)
Unidad de Citogenética Molecular

Madrid
MADRID
Combination of nanomedicine and immunotherapy for the treatment of neuroblastoma
Hospital Infantil Universitario Niño Jesús
Servicio de Oncohematología

Washington
ADDRESS: NOT PROVIDED - US
Targeting olig2 co-regulators for malignant glioma therapy
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Drug repurposing screening for rare and neglected diseases
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Deconstruct tumor microenvironment in medulloblastoma
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Focal sustained release chemotherapy-loaded biomaterials at tumor sites
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Targeting bet-bromodomains in neuroblastoma
Institution: Information not provided - US

Finland
HELSINKI
Lessons learned from the embryo to help understand neuroblastoma formation
University of Helsinki
Department of Biochemistry and Developmental Biology

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
Genetics and molecular bases of central hypoventilation syndromes (Ondine's Curse)
Institution: Information not provided - FR

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
Genetics and molecular bases of malformative syndromes with tumour predisposition
Institution: Information not provided - FR

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
PRIMAGE: PRedictive In-silico Multiscale Analytics to support cancer personalized diaGnosis and prognosis, Empowered by imaging biomarkers - FR
Institution: Information not provided - FR

AUVERGNE-RHONE-ALPES
LYON
Metastatic program of neuroblastoma: elucidating the molecular dialogues of tumor cells with the embryonic microenvironment
Institut NeuroMyoGène
NEURO-DÉVELOPPEMENT, CANCER ET SIGNALISATION

ILE-DE-FRANCE
PARIS
LIQUIDHOPE: Advancing liquid biopsies for monitoring and personalized treatment of children with neuroblastomas - FR
CLCC Institut Curie
Institut Curie

Suisse Romande
LAUSANNE
Deciphering the functional role of ALK and TWIST1 in neuroblastoma development and progression
CHUV
Institut universitaire de Pathologie

Suisse Romande
LAUSANNE
Mechanisms of Transcription Factors-mediated chromatin regulation in pediatric tumors development
CHUV
Institut universitaire de Pathologie

Nordrhein-Westfalen
DÜSSELDORF
Targeting HOTAIRM1 in Glioblastoma Multiforme
Universitätsklinikum Düsseldorf
Hirntumor-Referenzzentrum der DGNN

WIEN
ADDRESS: NOT PROVIDED - AT
RESURGE: Randomized Controlled Comparative Phase II Trial on Surgery for Glioblastoma Recurrence - AT
Institution: Information not provided - AT

WIEN
ADDRESS: NOT PROVIDED - AT
Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma - AT
Institution: Information not provided - AT

WIEN
WIEN
TERT promoter mutations and cancer aggressiveness
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Onkologie

WIEN
WIEN
CDK 4/6 inhibitors as a new therapeutic strategy in pediatric brain tumors
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Neonatologie, Pädiatrische Intensivmedizin und Neuropädiatrie

WIEN
WIEN
Fibroblast Growth Factor Receptor 4 in Glioblastoma
Medizinische Universität Wien
Institut für Krebsforschung

Baleares
PALMA DE MALLORCA
Integrative characterization of molecular biomarkers for the precision diagnosis and treatment of patients with glioblastoma
IdISBa - Fundació Institut d'Investigació Sanitaria Illes Balears
BIOCANCER: Grupo de Biología Celular del Cáncer

Castilla - La Mancha
ALBACETE
Nanomedicine for glioblastoma therapy
Universidad de Castilla-La Mancha. Campus de Albacete. Facultad de Medicina
Unidad Neurodeath

Cataluña
BADALONA
Molecular characterization of glioblastoma: clinical-radiological, genomic, transcriptomic and immunohistochemical correlation
ICO Badalona - Hospital Germans Trias i Pujol
Servicio de Oncología Médica

Comunidad Valenciana
VALENCIA
Integrative personal omics profiles in glioblastoma recurrence and therapy resistance
IIS La Fe - Instituto de Investigación Sanitaria La Fe
GIBI230: Grupo de Investigación Biomédica en Imagen

Galicia
SANTIAGO DE COMPOSTELA
Silk-fibroin interventional nano-trap for the treatment of glioblastoma
Universidad de Santiago de Compostela. Facultad de Farmacia
I+D Farma

Madrid
MADRID
Nanomedicine for glioblastoma therapy
Hospital Universitario Ramón y Cajal
Servicio de Oncología Médica

Navarra
PAMPLONA
Role of RNU6 isolated from circulating exosomes as a potential diagnostic and follow-up biomarker for patients with glioblastoma
CIMA - Centro de Investigación Médica Aplicada
Grupo de Terapias avanzadas para tumores sólidos pediátricos

Washington
ADDRESS: NOT PROVIDED - US
Role of a novel troy-egfr complex in gliobastoma invasion and resistance
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Immunobiology of malignant glioma
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Glioblastoma phenotype modulation through mirna control of wnt signaling
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Autophagy regulation of glioblastoma tumorigenesis and responses to therapy
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Endothelial plasticity in glioma vascularization and therapy resistance
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Targeting prmt5 in cancer initiating cells as a new therapy for glioblastoma
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Hypoxia regulates notch turnover in glioma stem cells through vasorin
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Identification of small molecule inhibitors of phf5a for glioblastoma
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Comparative mammalian genomics
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Cytochrome c oxidase: biomarker in newly diagnosed glioblastoma multiforme
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Dual inhibition of mitochondrial matrix chaperones and anti-apoptotic bcl-2 family members for glioblastoma therapy.
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Glioblastoma stem cell-derived pericytes and cancer invasion
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Investigation of histone h3 post-translational modifications in pediatric brainstem glioma
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Modeling malignant progression in glioma
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Nanofiber matrices to improve neural stem cell-mediated cancer therapy
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Neuronal activity-regulated mechanisms of glioma growth
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Neuroimmunology of malignant brain tumors: innate mechanisms
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Novel k27m mutation-derived neoantigen for t cell therapy in gliomas
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Role of glud2 as a metabolic driver of gliomas with idh1 mutations
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Plexin-b2 function in glioma invasion and glioma stem cell maintenance
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Radiation + temozolomide induced mutation and malignant progression of gbm
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Quantifying differences in mtor activity and tumor development between neural stem cell microdomains
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Regulation of glioblastoma stem-like cells by cdc20-anaphase-promoting complex
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Systemic gene therapy for glioblastoma
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
The mayo gbm xenograft national resource
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Targeting epha2 in glioblastoma
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Targeting mechanisms of acquired temozolomide resistance in glioblastoma
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Selective targeting of glioma stem cells through sema3c/plexind1
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Ubiquitination and deubiquitination of c-myc in glioblastoma
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Chromatin modifications in gbm-propagating cells
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Cellular plasticity and equilibrium in gbm progression
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Characterization of a microrna network regulating glioblastoma epigenetics; cell reprogramming and dna repair
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Contributions of idh1 mutation to alternative lengthening of telomeres in lower-grade glioma
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Dual targeting of brain tumor initiating cells through inhibition of bmi1 and ezh2
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Exploiting mtap deletion for gbm therapeutics
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Interplay between ubiquitination and epigenetic regulation of egfr signaling in gliomagenesis.
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Mechanism of regulation of progenitor proliferation and transformation
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Mechanisms of riok2 function in glioblastoma
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
The role of tumor associated macrophages in glioblastoma
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Targeting hyaluronan-mediated motility receptor in glioblastoma stem cells
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Targeting kif11 to treat glioblastoma invasion and proliferation
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
The immunosuppressive role of glioblastoma-derived macrophage migration inhibitor factor
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Uncovering therapeutic targets in pediatric high grade gliomas with the h3k27m mutation
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Translational investigation of xpo1 inhibition in high-grade glioma and diffuse intrinsic pontine glioma
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Tissue factor as a key determinant of idh1 mutant versus idh1 wild-type glioma thrombosis and malignancy
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Single cell analysis of the infiltrative margins of glioblastoma and post-treatment recurrence
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Engineering stem cell therapies to understand and overcome glioblastoma adaption
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Physical-chemical aspects of cell and tissue excitability
Institution: Information not provided - US

Washington
ADDRESS: NOT PROVIDED - US
Therapeutically relevant targets of twist1 dimers in glioma
Institution: Information not provided - US

Finland
KUOPIO
New therapeutic treatments for malignant glioma
Itä-Suomen yliopisto
A.I.Virtanen -Instituutti

Finland
KUOPIO
LAT1-targeted prodrugs for improved drug delivery to invasive glioma cells
University of Eastern Finland
Faculty of Health Sciences

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
GLIOMA-PRD: Multi-parametric analysis of the evolution and progression of low grade glioma - FR
Institution: Information not provided - FR

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
IMMUNOGLIO: Deciphering immune response against glioblastoma to find new targets - FR
Institution: Information not provided - FR

AUVERGNE-RHONE-ALPES
ILLKIRCH
Systems biology of integrin inhibition-induced apoptosis for novel glioblastoma treatment
LBP - Laboratory of Bioimaging and Pathologies
Tumoral signaling and therapeutic targets

AUVERGNE-RHONE-ALPES
LYON
Identification of networks of alternative splicing events that coordinate cell heterogeneity and resistance to glioblastoma therapies
Centre de Recherche en Cancérologie Lyon-Est
Diversité du transcriptome des cellules souches

BRETAGNE
RENNES
Tumor activity of IRE1 and remodeling of the immune microenvironment of glioblastomas
Centre de Lutte Contre le Cancer Eugène Marquis
Oncogenesis, Stress & Signaling Laboratory

NORMANDIE
CAEN
Radiosensitization and reoxygenation of tumors via zeolites containing gadolinium: an original theranostic approach for glioblastomas
GIP CYCERON
Equipe CERVOxy | Hypoxie, physiopathologies cérébrovasculaire et tumorale

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE
Development of a new drug therapy for glioblastoma
Parc scientifique et technologiques de Luminy
Pharmaxon

CENTRO
BRAGA
O Transcriptoma da Homeoproteína Oncogénica HOXA9 em Glioblastomas Humanos: Caracterização e Consequências Funcionais
Universidade do Minho
Centro de Ciências e Tecnologias de Computação

Cambridgeshire
CAMBRIDGE
Surgically Induced Neurological Deficits in Glioblastomas (SIND Study) (SIND)
University of Cambridge
MRC Cancer Unit

Region Uppsala
UPPSALA
Separation of human glioblastoma brain tumor subpopulations in search for expression profiles, connected to tumor initiating portability and drug resistance
Uppsala Universitet
Department of Immunology, Genetics and Pathology

Suisse Romande
EPALINGES
Epigenetic landscape of gliomas and their implications for tumor biology and treatment of cancer
Université de Lausanne UNIL
Laboratoire de biologie et génétique des tumeurs cérébrales (LBGT)
Projetos de investigação multicêntricos
- Institution: Information not provided - DE
- Institution: Information not provided - IT
- Fondazione IRCCS Istituto Nazionale dei Tumori
- S.S. di Epidemiologia Valutativa
- Fondazione IRCCS Istituto Nazionale dei Tumori
- S.S. di Epidemiologia Valutativa
- Northern Institute for Cancer Research, Medical School, Newcastle University
- Northern Institute for Cancer Research
- Institut Curie
- Macromolécules et Microsystèmes en Biologie et en Medecine
- Deutsches Krebsforschungszentrum
- KITZ - Hopp-Kindertumorzentrum Heidelberg
- Universitäts-Kinderklinik Würzburg
- Kinderklinik und Poliklinik
- University College Dublin
- Systems Biology Ireland
- Istituto Ortopedico Rizzoli - Centro di Ricerca e Poliambulatorio
- S.C. Laboratorio di Oncologia Sperimentale
- Institution: Information not provided - DE
- St. Anna Kinderkrebsforschung
- Children's Cancer Research Institute
- Institution: Information not provided - ES
- Institution: Information not provided - FR
- Institution: Information not provided - FR
- Fondazione IRCCS Istituto Neurologico "Carlo Besta"
- Fondazione I.R.C.C.S. Istituto Neurologico "C. Besta"

Berlin
ADDRESS: NOT PROVIDED - DE
TORPEDO: Targeting Of Resistance in PEDiatric Oncology

EMILIA ROMAGNA
ADDRESS: NOT PROVIDED - IT
TRANSCAN-2: Aligning national/regional translational cancer research programmes and activities

LOMBARDIA
MILANO
RARECARE: surveillance of rare cancers in Europe

LOMBARDIA
MILANO
RARECARENet: Information network on rare cancers

Tyne & Wear
NEWCASTLE UPON TYNE
EPOC: European paediatric oncology off-patent medicines consortium

ILE-DE-FRANCE
ORSAY
CAMINEMS: Integrated Micro-Nano-Opto Fluidic systems for high-content diagnosis and studies of rare cancer cells

Baden-Württemberg
HEIDELBERG
BRCAddict: Harnessing BRCAness as a therapeutic target in high-risk pediatric solid tumors

Bayern
WÜRZBURG
ATRTPepVac: Exploiting the peptidome of atypical teratoid/rhabdoid tumors - characterization of novel tumor-associated antigens for immunotherapy in order to maintain long-term remissions

County Dublin
DUBLIN 4
ASSET: Analysing and Striking the Sensitivities of Embryonal Tumours

EMILIA ROMAGNA
BOLOGNA
PROTHETS: prognosis and therapeutic targets in the 'Ewing' family of tumors (FINISHED)

Berlin
ADDRESS: NOT PROVIDED - DE
LIQUIDHOPE:: Advancing Liquid Biopsies for Monitoring and Personalized Treatment of Children with Neuroblastomas

WIEN
WIEN
ONTHETRRAC: Overcoming Neuroblastoma Tumour HETerogeneity, Resistance and RecurrAnCe

Madrid
ADDRESS: NOT PROVIDED - ES
PRIMAGE: PRedictive In-silico Multiscale Analytics to support cancer personalized diaGnosis and prognosis, Empowered by imaging biomarkers

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
IMMUNOGLIO: Deciphering immune response against glioblastoma to find new targets

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
GLIOMA-PRD: Multi-parametric analysis of the evolution and progression of low grade glioma

LOMBARDIA
MILANO